ZappRx and Bayer Partner to Improve Access to Specialty Medications

Health Care Finance News
18 Jan, 2019 ,

ZappRx is adding therapies  for patients suffering from pulmonary hypertension and relapsing remitting multiple sclerosis from Bayer to its specialty prescription and prior authorization platform for providers. In the past it used to take several weeks, or months but this change will reduce time and help in reducing the administrative burden along with helping in speeding up the process for patients to get their specialty medications within days.